The exclusive, invitation-only, UBS-hosted, Genomics 2.0 and MedTech Innovations Summit, provided high quality content across a wide array of end markets, products & services. The summit consisted of presentations, panels, thematic discussions, investor meetings, keynotes addresses and more.
Genomics topics included liquid biopsy, synthetic biology, cancer screening, 3D spatial, regulatory & reimbursement, new technologies, data & informatics, consumer genomics & government funding / initiatives.
MedTech topics included robotic surgery, diabetes technology, neuromodulation, aesthetics, medication delivery and management, home health, urologic interventions, remote monitoring, wound care, structural heart innovations, patient workflow management and dialysis, among others.
XIFIN participated as an attendee.
UBS provides financial advice and solutions to wealthy, institutional and corporate clients worldwide, as well as private clients in Switzerland. The operational structure of the Group is comprised of our Corporate Center and five business divisions: Wealth Management, Wealth Management Americas, Personal & Corporate Banking, Asset Management and the Investment Bank. UBS's strategy builds on the strengths of all of its businesses and focuses its efforts on areas in which it excels, while seeking to capitalize on the compelling growth prospects in the businesses and regions in which it operates, in order to generate attractive and sustainable returns for its shareholders. All of its businesses are capital-efficient and benefit from a strong competitive position in their targeted markets.